Robert M. Silver — Endo Lab

article 2024

1073 Placenta Accreta Spectrum and Endometriosis

·doi:10.1016/j.ajog.2023.11.1100

article 2020

Circulating Vascular Endothelial Growth Factor and Soluble fms-Like Tyrosine Kinase-1 as Biomarkers for Endometrial Remodeling Across the Menstrual Cycle

Obstetrics and gynecology ·doi:10.1097/aog.0000000000004171

OBJECTIVE: To characterize variation in circulating vascular endothelial growth factor (VEGF) and its receptor, soluble fms-like tyrosine kinase-1 (sFLT-1), across the menstrual cycle in normal ovulating women in relation to reproductive ho…

article 2020

Low-dose aspirin in reproductive health: effects on menstrual cycle characteristics

·doi:10.1016/j.fertnstert.2020.06.022

ObjectiveTo estimate the effect of daily 81 mg low-dose aspirin (LDA) on menstrual cycle length and hormone profiles.DesignSecondary analysis of a trial evaluating the effect of daily LDA or placebo on live birth among women with one or two…

article 2019

Ambient temperature and humidity during key phases of the menstrual cycle and reproductive outcomes: differences by season and low-dose aspirin

·doi:10.1016/j.fertnstert.2019.07.975

article 2018

Family history of gynecological disorders, time to pregnancy and pregnancy outcomes

·doi:10.1016/j.fertnstert.2018.07.435

2015

Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial.

The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2015-2474

ObjectiveThe objective of the study was to evaluate whether anti-Müllerian hormone (AMH) is associated with fecundability among women with proven fecundity and a history of pregnancy loss.DesignThis was a prospective cohort study within a m…